People of Amgen: Meet Brent Serson

People of Amgen: Meet Brent Serson

  • Introduction

  • View Video Transcript

Brent Serson, the director of strategic accounts at Amgen Canada, knows about colorectal cancer all too well. Both his maternal grandfather and his father were diagnosed with, and subsequently passed from, the disease. Because the disease is prevalent on both sides of his family tree, Brent faces a higher risk of developing colorectal cancer.

Amgen’s research and advancements in new technologies balanced with its mission to serve patients means that people like Brent have the privilege to work in an environment that has personal meaning for them. Watch this video to hear Brent’s story.

My colorectal cancer story has two pieces to it. One is my grandfather on my mom's side. When I was five years old he passed away from colon cancer. The other story is my father who had colorectal cancer and other illnesses. I started learning about colorectal cancer once I learned more about the genetic predisposition that I had to it.

I wanna to be there for my kids, I wanna walk my daughters down the aisle, I wanna to see my grandkids. I want to I'd be there for my wife, my family and experience life with them. I don't want it to end abruptly because of colorectal cancer if I can avoid it.

When I started working at Amgen I found I really fell in love with the patient focus and a lot of companies talk about the patient focus, Amgen lives the patient focus, and I've been here 10 years. I've never seen them not.

I enjoy coming to work every day, and I know that we're making efforts to get medicines to patients that might not have any option and we are giving them an option. One of the areas about Amgen I think I'm most proud of is the research and development side.

They focus a lot of energy into technologies, and treatments that are moving into places that there's currently unmet needs. I know for colorectal cancer there are continuing to be options available for patients that my grandfather never had, my dad never got access to because of the issues he had, and one day I might need. So it's an important thing for all patients, including potentially myself. Which I think is easy to be proud of.